The cure rate of acute myeloid leukemia M5 is related to the stage of the disease, with a cure rate of 50% to 60% in low-risk patients and about 30% to 40% in high-risk patients. Acute myeloid leukemia M5 is a more difficult myeloid leukemia to treat, and the cure rate depends mainly on the degree of risk, with a higher cure rate in patients with a good prognosis and a lower cure rate in patients with a poor prognosis. If the patient has a poor prognosis but receives standardized treatment or even takes stronger therapeutic measures, including hematopoietic stem cell transplantation, the cure rate can reach 50% to 60%. Specific drugs include cytarabine and Zoerythromycin. Because the cure rate is different at each stage, once you are found to have the disease, you should be treated as soon as possible under the guidance of your physician.